CHO Pharma has been growing earnings at an average annual rate of 0.6%, while the Pharmaceuticals industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 16.8% per year.
How CHO Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
TPEX:6586 Revenue, expenses and earnings (TWD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
1
-290
40
287
30 Sep 25
2
-260
37
261
30 Jun 25
3
-230
35
235
31 Mar 25
3
-221
33
227
31 Dec 24
4
-212
32
219
30 Sep 24
2
-234
32
209
30 Jun 24
1
-255
33
199
31 Mar 24
1
-281
31
219
31 Dec 23
0
-306
30
239
30 Sep 23
0
-317
27
277
30 Jun 23
0
-327
24
315
31 Mar 23
0
-333
24
321
31 Dec 22
0
-338
25
326
30 Sep 22
2
-298
24
284
30 Jun 22
4
-257
23
242
31 Mar 22
4
-232
22
218
31 Dec 21
4
-206
20
194
30 Sep 21
2
-223
21
212
30 Jun 21
0
-240
21
230
31 Mar 21
0
-269
21
259
31 Dec 20
0
-297
22
288
30 Sep 20
0
-328
23
317
30 Jun 20
0
-359
24
347
31 Mar 20
0
-359
24
346
31 Dec 19
0
-358
25
345
30 Sep 19
0
-347
24
335
30 Jun 19
0
-337
23
325
31 Mar 19
0
-322
23
311
31 Dec 18
0
-307
22
297
30 Sep 18
0
-309
27
295
30 Jun 18
0
-312
32
294
31 Mar 18
0
-310
34
291
31 Dec 17
0
-309
35
289
30 Sep 17
1
-293
32
276
30 Jun 17
1
-278
30
264
31 Mar 17
1
-262
25
254
31 Dec 16
2
-245
21
243
30 Sep 16
1
-203
14
211
30 Jun 16
1
-161
7
178
31 Mar 16
0
-135
3
160
Quality Earnings: 6586 is currently unprofitable.
Growing Profit Margin: 6586 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6586 is unprofitable, but has reduced losses over the past 5 years at a rate of 0.6% per year.
Accelerating Growth: Unable to compare 6586's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6586 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-5%).
Return on Equity
High ROE: 6586 has a negative Return on Equity (-11.77%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/24 11:42
End of Day Share Price
2026/06/24 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CHO Pharma, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.